Highlights of the updated Dutch evidence- and consensus-based guideline on psoriasis 2017.

Autor: van der Kraaij GE; Department of Dermatology, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.; Public Health, Infection and Immunity, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.; Dutch Society of Dermatology and Venereology, Utrecht, the Netherlands., Balak DMW; University Medical Centre Utrecht, Utrecht, the Netherlands., Busard CI; Department of Dermatology, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.; Public Health, Infection and Immunity, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands., van Cranenburgh OD; Department of Dermatology, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.; Dutch Skin Foundation, Nieuwegein, the Netherlands., Chung Y; Dutch Society of Dermatology and Venereology, Utrecht, the Netherlands., Driessen RJB; Radboud University Medical Centre, Nijmegen, the Netherlands., de Groot M; Antonius Hospital, Sneek/Emmeloord, the Netherlands., de Jong EMGJ; Radboud University Medical Centre, Nijmegen, the Netherlands.; Radboud University Nijmegen, the Netherlands., Kemperman PMJH; Department of Dermatology, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.; Waterlandziekenhuis, Purmerend, the Netherlands., de Kort WJA; Amphia Hospital, Breda, the Netherlands., Karsch SA; Dutch Society of Dermatology and Venereology, Utrecht, the Netherlands., Lamberts A; Dutch Society of Dermatology and Venereology, Utrecht, the Netherlands.; University Medical Center Groningen, Groningen, the Netherlands., Lecluse LLA; Bergman Clinics and U-clinic, Amsterdam, the Netherlands., van Lümig PPM; Radboud University Medical Centre, Nijmegen, the Netherlands., Menting SP; Department of Dermatology, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands., Prens EP; Erasmus Medical Centre, Rotterdam, the Netherlands., van den Reek JMPA; Radboud University Medical Centre, Nijmegen, the Netherlands., Seyger MMB; Radboud University Medical Centre, Nijmegen, the Netherlands., Thio HB; Erasmus Medical Centre, Rotterdam, the Netherlands., Veldkamp WR; Dutch Society of Dermatology and Venereology, Utrecht, the Netherlands.; Radboud University Nijmegen, the Netherlands., Wakkee M; Erasmus Medical Centre, Rotterdam, the Netherlands., Nast A; Department of Dermatology, Venereology und Allergy, Division of Evidence-Based Medicine (dEBM), Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany., Jacobs A; Department of Dermatology, Venereology und Allergy, Division of Evidence-Based Medicine (dEBM), Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany., Rosumeck S; Department of Dermatology, Venereology und Allergy, Division of Evidence-Based Medicine (dEBM), Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany., Spuls Chair PI; Department of Dermatology, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.; Public Health, Infection and Immunity, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.

Publikováno v: The British journal of dermatology [Br J Dermatol] 2019 Jan; Vol. 180 (1), pp. 31-42.